Common Contracts
7 similar Underwriting Agreement contracts by Avid Bioservices, Inc., First Defiance Financial Corp
Avid Bioservices, Inc. 3,333,335 Shares of Common Stock ($0.001 par value) UNDERWRITING AGREEMENTUnderwriting Agreement • December 14th, 2020 • Avid Bioservices, Inc. • Pharmaceutical preparations • New York
Avid Bioservices, Inc., a Delaware corporation (the “Company”) confirms its agreement with RBC Capital Markets, LLC (“RBC Capital Markets”) and each of the other Underwriters named in Exhibit A hereto (collectively, the “Underwriters,” which term shall also include any underwriter substituted as hereinafter provided in Section 10 hereof), for whom RBC Capital Markets is acting as representative (in such capacity, the “Representative”), with respect to the issue and sale by the Company of 3,333,335 shares (the “Initial Securities”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”), and the purchase by the Underwriters, acting severally and not jointly, of the respective numbers of Initial Securities set forth in said Exhibit A hereto, and with respect to the grant by the Company to the Underwriters, acting severally and not jointly, of the option described in Section 2(b) hereof to purchase all or any part of 500,000 additional shares of Common Stock (the “O
UNDERWRITING AGREEMENTUnderwriting Agreement • June 15th, 2012 • First Defiance Financial Corp • Savings institution, federally chartered • New York
UNDERWRITING AGREEMENTUnderwriting Agreement • June 13th, 2012 • New York
UNDERWRITING AGREEMENTUnderwriting Agreement • June 13th, 2012 • New York
UNDERWRITING AGREEMENTUnderwriting Agreement • March 29th, 2012 • New York
First Financial Holdings, Inc., a Delaware corporation (the “Company”), First Federal Savings and Loan Association of Charleston (the “Bank”) and the United States Department of the Treasury (the “Selling Shareholder”) each confirms its agreement with Merrill Lynch, Pierce, Fenner & Smith Incorporated (“Merrill Lynch” and together with any underwriter substituted as hereinafter provided in Section 11 hereof, the “Underwriters”), for whom Merrill Lynch is acting as Representative (in such capacity, the “Representative”), with respect to the sale by the Selling Shareholder and the purchase by the Underwriters, acting severally and not jointly, of the respective numbers of shares of Fixed Rate Cumulative Perpetual Series A Preferred Stock, par value $0.01 per share, of the Company (the “Preferred Stock”) set forth in Schedule A hereto. The aforesaid 65,000 shares of Preferred Stock to be purchased by the Underwriters are referred to herein, collectively, as the “Securities.”
UNDERWRITING AGREEMENTUnderwriting Agreement • March 28th, 2012 • New York
UNDERWRITING AGREEMENTUnderwriting Agreement • March 28th, 2012 • New York
